Breaking News Instant updates and real-time market news.

CYAD

Celyad

$27.82

2.94 (11.82%)

05:14
11/30/18
11/30
05:14
11/30/18
05:14

Celyad doses first mCRC patient in Phase 1 alloSHRINK trial

Celyad announced the injection of the first patient in the Phase 1 alloSHRINK trial evaluating the company's non-gene edited allogeneic CAR-T therapy, CYAD-101, administered concurrently with FOLFOX chemotherapy in the treatment of patients with unresectable metastatic colorectal cancer.

  • 01

    Dec

  • 03

    Dec

  • 10

    Dec

CYAD Celyad
$27.82

2.94 (11.82%)

11/12/18
PIPR
11/12/18
NO CHANGE
Target $51
PIPR
Overweight
Celyad price target lowered to $51 from $74 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Celyad to $51 after rolling forward his discount period to 2019. The analyst, however, keeps an Overweight rating on the shares after the company updated solid tumor data from the Think and Shrink studies of CYAD-01. Celyad will report Think data on 12 relapsed/refractory acute myeloid leukemia patients in December, Tenthoff tells investors in a research note. He also believes the company has enough cash to fund its operations through mid-2020.
10/30/18
WBLR
10/30/18
INITIATION
WBLR
Outperform
William Blair starts Celyad with Outperform, $53 fair value estimate
William Blair analyst Raju Prasad initiated coverage of Celyad with an Outperform rating and $53 fair value estimate. Celyad's lead candidate, CYAD-01, is an autologous NKG2D chimeric antigen receptor (CAR)-T cell therapy being developed to treat both solid tumors and hematologic or liquid cancers, Prasad tells investors in a research note. The analyst believes the company's platform has several advantages, including a product profile that could be suitable for repeat injections, the ability to treat multiple tumor types using one CAR construct and the potential to show an adaptive immune response. Celyad's allogeneic platform is "significantly underappreciated," says Prasad.
10/30/18
WBLR
10/30/18
INITIATION
WBLR
Outperform
Celyad initiated with an Outperform at William Blair
William Blair analyst Raju Prasad started Celyad with an Outperform rating.
07/02/18
07/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Howard Hughes (HHC) initiated with a Buy at Jefferies. 2. Celyad (CYAD) initiated with a Buy at H.C. Wainwright. 3. Veoneer (VNE) initiated with a Sector Perform at RBC Capital. 4. Melinta Therapeutics (MLNT) initiated with an Overweight at Cantor Fitzgerald. 5. Axon (AAXN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

16:39
11/14/19
11/14
16:39
11/14/19
16:39
General news
Fed Balance Sheet Level data reported »

Week of 11/13 Fed Balance…

QGEN

Qiagen

$37.31

1.785 (5.03%)

16:38
11/14/19
11/14
16:38
11/14/19
16:38
Initiation
Qiagen initiated  »

Qiagen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ILMN

Illumina

$298.43

0.32 (0.11%)

16:36
11/14/19
11/14
16:36
11/14/19
16:36
Initiation
Illumina initiated  »

Illumina initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REDU

Rise Education

$7.42

-0.24 (-3.13%)

16:35
11/14/19
11/14
16:35
11/14/19
16:35
Earnings
Rise Education reports Q3 Net income RMB 39.6M, up 22.4% from last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

16:35
11/14/19
11/14
16:35
11/14/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 11/4 Money Supply…

RGEN

Repligen

$81.70

-1.45 (-1.74%)

16:34
11/14/19
11/14
16:34
11/14/19
16:34
Initiation
Repligen initiated  »

Repligen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KLIC

Kulicke & Soffa

$25.18

-0.22 (-0.87%)

16:33
11/14/19
11/14
16:33
11/14/19
16:33
Earnings
Kulicke & Soffa sees Q1 revenue $130M-$150M, consensus $141.04M »

Looking forward, Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 09

    Dec

TECH

Bio-Techne

$203.87

-1.02 (-0.50%)

16:33
11/14/19
11/14
16:33
11/14/19
16:33
Initiation
Bio-Techne initiated  »

Bio-Techne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

KLIC

Kulicke & Soffa

$25.18

-0.22 (-0.87%)

16:32
11/14/19
11/14
16:32
11/14/19
16:32
Earnings
Kulicke & Soffa reports Q4 adjusted EPS 14c, consensus 11c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 09

    Dec

NSTG

NanoString

$23.71

0.19 (0.81%)

16:32
11/14/19
11/14
16:32
11/14/19
16:32
Initiation
NanoString initiated  »

NanoString initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AGRX

Agile Therapeutics

$2.37

0.19 (8.72%)

16:31
11/14/19
11/14
16:31
11/14/19
16:31
Hot Stocks
Agile Therapeutics announces FDA extension of Twirla NDA review period »

Agile Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

PKI

PerkinElmer

16:31
11/14/19
11/14
16:31
11/14/19
16:31
Initiation
PerkinElmer initiated  »

PerkinElmer initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSBC

WesBanco

$37.50

0.11 (0.29%)

, OLBK

Old Line Bancshares

$29.41

0.17 (0.58%)

16:31
11/14/19
11/14
16:31
11/14/19
16:31
Hot Stocks
WesBanco, Old Line announce approval of merger »

WesBanc (WSBC) and Old…

WSBC

WesBanco

$37.50

0.11 (0.29%)

OLBK

Old Line Bancshares

$29.41

0.17 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

PKI

PerkinElmer

$88.13

0.815 (0.93%)

16:31
11/14/19
11/14
16:31
11/14/19
16:31
Initiation
PerkinElmer initiated  »

PerkinElmer initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
11/14/19
11/14
16:30
11/14/19
16:30
Options
Preliminary option volume of 20.0M today »

Preliminary option volume…

BABA

Alibaba

$182.69

0.21 (0.12%)

, AVGO

Broadcom

$308.99

-4.54 (-1.45%)

16:29
11/14/19
11/14
16:29
11/14/19
16:29
Hot Stocks
Appaloosa increases stake in Alphabet, lowers stake in UnitedHealth »

David Tepper's…

BABA

Alibaba

$182.69

0.21 (0.12%)

AVGO

Broadcom

$308.99

-4.54 (-1.45%)

BA

Boeing

$367.42

5 (1.38%)

I

Intelsat

$12.13

-2.28 (-15.82%)

CNC

Centene

$54.66

-0.7 (-1.26%)

GOOG

Alphabet

$1,312.37

14.76 (1.14%)

MU

Micron

$46.82

0.53 (1.15%)

FB

Facebook

$193.15

-0.05 (-0.03%)

AMZN

Amazon.com

$1,754.57

0.73 (0.04%)

ADBE

Adobe

$294.57

1.16 (0.40%)

UNH

UnitedHealth

$255.76

2.46 (0.97%)

HUM

Humana

$317.94

-0.95 (-0.30%)

COOP

Mr. Cooper

$12.48

-0.255 (-2.00%)

CWEN

Clearway Energy

$19.85

0.515 (2.66%)

AGN

Allergan

$182.47

0.91 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 10

    Dec

  • 12

    Dec

  • 13

    Dec

  • 23

    Jan

DHR

Danaher

$136.13

-0.92 (-0.67%)

16:29
11/14/19
11/14
16:29
11/14/19
16:29
Initiation
Danaher initiated  »

Danaher resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNO

CNO Financial

$17.53

-0.13 (-0.74%)

16:28
11/14/19
11/14
16:28
11/14/19
16:28
Hot Stocks
CNO Financial announces additional $500 share repurchase program »

CNO Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$49.20

0.56 (1.15%)

16:28
11/14/19
11/14
16:28
11/14/19
16:28
Initiation
Bruker initiated  »

Bruker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:27
11/14/19
11/14
16:27
11/14/19
16:27
Hot Stocks
Nvidia expects 'strong' sequential Data Center growth in Q4 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

EXAS

Exact Sciences

$79.12

1 (1.28%)

16:26
11/14/19
11/14
16:26
11/14/19
16:26
Initiation
Exact Sciences initiated  »

Exact Sciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

16:26
11/14/19
11/14
16:26
11/14/19
16:26
Initiation
Exact Sciences initiated  »

Exact Sciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$209.88

1.33 (0.64%)

16:26
11/14/19
11/14
16:26
11/14/19
16:26
Hot Stocks
Nvidia reports Q4 Gaming segment revenue $1.66B, down 6% from last year »

Reports Q4 Data Center…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 20

    Nov

  • 06

    Jan

DLPN

Dolphin Entertainment

$0.70

(0.00%)

16:25
11/14/19
11/14
16:25
11/14/19
16:25
Earnings
Dolphin Entertainment reports Q3 EPS (5c), consensus (6c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

A

Agilent

$76.75

-0.38 (-0.49%)

16:25
11/14/19
11/14
16:25
11/14/19
16:25
Initiation
Agilent initiated  »

Agilent initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.